Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 1780-1791

  Lindner, Inna ^a   Kharfan Dabaja, Mohamed A ^a   Ayala, Ernesto ^a   Kolonias, Despina ^a   Carlson, Louise M ^a   Beazer Barclay, Yasmin ^b   Scherf, Uwe ^b   Hnatyszyn, James H ^c   Lee, Kelvin P ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Gene Logic Inc   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD40 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL ESTER; PROTEIN KINASE C; TRANSCRIPTION FACTOR; VACCINE;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BLAST CELL; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LEVEL; CELL LINEAGE; CELL STRUCTURE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITE; DENDRITIC CELL; DOWN REGULATION; DRUG DESIGN; DRUG DEVELOPMENT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE ACTIVATION; TECHNIQUE;

EID: 0043092262     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.1780     Document Type: Article

References (79)

1. Fialkow, P. J., R. J. Jacobson, and T. Papayannopoulou. 1977, Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med. 63:125.
2. Rowley, J. D. 1973. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290 (Lett.).
3. Kolb, H. J., A. Schattenberg, J. M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, D. Niederwieser, et al. 1995. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86:2041.
4. Hill, G. R., D. N. Hart, A. F. Moore, and C. M. Morris. 1996. Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation. Pathology 28:51.
5. Gorre, M. E., M. Mohammed, K. Ellwood, N. Hsu, R. Paquette, P. N. Rao, and C. L. Sawyers. 2001. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293:876.
6. Choudhury, A., J. L. Gajewski, J. C. Liang, U. Popat, D. F. Claxton, K. O. Kliche, M. Andreeff, and R. E. Champlin. 1997. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89:1133.
7. + T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia. Blood 91:977.
8. + T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood 88:3522.
9. Heinzinger, M., C. F. Waller, A. von den Berg, A. Rosenstiel, and W. Lange. 1999. Generation of dendritic cells from patients with chronic myelogenous leukemia. Ann. Hematol. 78:181.
10. Choudhury, A., A. Toubert, S. Sutaria, D. Charron, R. E. Champlin, and D. F. Claxton. 1998. Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity. Crit. Rev. Immunol. 18:121.
11. Eibl, B., S. Ebner, C. Duba, G. Bock, N. Romani, M. Erdel, A. Gachter, D. Niederwieser, and G. Schuler. 1997. Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosomes Cancer 20:215.
12. Santiago-Schwarz, F., D. L. Coppock, A. A. Hindenburg, and J. Kern. 1994. Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 84:3054.
13. Choudhury, B. A., J. C. Liang, E. K. Thomas, L. Flores-Romo, Q. S. Xie, K. Agusala, S. Sutaria, I. Sinha, R. E. Champlin, and D. F. Claxton. 1999. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 93:780.
14. + acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood 94:2048.
15. Oehler, L., A. Berer, M. Kollars, F. Keil, M. Konig, M. Waclavicek, O. Haas, W. Knapp, K. Lechner, and K. Geissler. 2000. Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia. Ann. Hematol. 79:355.
16. Harrison, B. D., J. A. Adams, M. Briggs, M. L. Brereton, and J. A. Yin. 2001. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia. Blood 97:2764.
17. Thurner, B., I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender, C. Maczek, D. Schreiner, P. von den Driesch, et al. 1999. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190:1669.
18. + progenitor-derived dendritic cell vaccine. Cancer Res. 61:6451.
19. Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GMC-SF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
20. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J. Exp. Med. 182:1111.
21. + dendritic cell phenotype. Arch. Dermatol. Res. 293:147.
22. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 185:341.
23. Czerniecki, B. J., C. Carter, L. Rivoltini, G. K. Koski, H. I. Kim, D. E. Weng, J. G. Roros, Y. M. Hijazi, S. Xu, S. A. Rosenberg, et al. 1997. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J. Immunol. 159:3823.
24. + hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J. Immunol. 160:3689.
25. Koski, G. K., G. N. Schwartz, D. E. Weng, R. E. Gress, F. H. Engels, M. Tsokos, B. J. Czerniecki, and P. A. Cohen. 1999. Calcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood 94:1359.
26. + progenitor to dendritic cell differentiation from a human cell line model. J. Immunol. 162:3237.
27. Waclavicek, M., A. Berer, L. Oehler, J. Stockl, E. Schloegl, O. Majdic, and W. Knapp. 2001. Calcium ionophore: a single reagent for the differentiation of primary human acute myelogenous leukaemia cells towards dendritic cells. Br. J. Haematol. 114:466.
28. Engels, F. H., G. K. Koski, I. Bedrosian, S. Xu, S. Luger, P. C. Nowell, P. A. Cohen, and B. J. Czerniecki. 1999. Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells. Proc. Natl. Acad. Sci. USA 96:10332.
29. + haematopoietic progenitors by PMA and in serum-free medium. Clin. Exp. Immunol. 125:237.
30. Westers, T. M., A. G. Stam, R. J. Scheper, J. C. Regelink, A. W. Nieuwint, G. J. Schuurhuis, A. A. van de Loosdrecht, and G. J. Ossenkoppele. 2003. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia. Cancer Immunol. 52:17.
31. Koski, G. K., G. N. Schwartz, D. E. Weng, B. J. Czerniecki, C. Carter, R. E. Gress, and P. A. Cohen. 1999. Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. J. Immunol. 163:82.
32. Charbonnier, A., B. Gaugler, D. Sainty, M. Lafage-Pochitaloff, and D. Olive. 1999. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur. J. Immunol. 29:2567.
33. Kohler, T., R. Plettig, W. Wetzstein, M. Schmitz, M. Ritter, B. Mohr, U. Schaekel, G. Ehninger, and M. Bornhauser. 2000. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells 18:139.
34. Wang, C., H. M. Al-Omar, L. Radvanyi, A. Banerjee, D. Bouman, J. Squire, and H. A. Messner. 1999. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-α. Exp. Hematol. 27:1176.
35. Mohty, M., D. Jarrossay, M. Lafage-Pochitaloff, C. Zandotti, F. Briere, X. N. de Lamballeri, D. Isnardon, D. Sainty, D. Olive, and B. Gaugler. 2001. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 98:3750.
36. bcr/abl gene of the Philadelphia chromosome. Science 247:824.
37. + cells with a BCR/ABL-containing retroviral vector. Blood 97: 2406.
38. Gishizky, M. L., and O. N. Witte. 1992. Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. Science 256:836.
39. Pierce, A., E. Spooncer, S. Ainsworth, and A. D. Whetton. 2002. BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor. Oncogene 21:3068.
40. Takahira, H., J. Nishimura, K. Shibata, J. Hirata, T. Umemura, and H. Nawata. 1990. Lineage non-specific down regulation of P210bcr/abl in the CML cell line, KU-812-F, during differentiation. Leuk. Res. 14:801.
41. Eisbruch, A., M. Blick, M. J. Evinger-Hodges, M. Beran, B. Andersson, J. U. Gutterman, and R. Kurzrock. 1988. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line. Cancer 62:1171.
42. Anafi, M., A. Gazit, A. Zehavi, Y. Ben-Neriah, and A. Levitzki. 1993. Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate. Blood 82:3524.
43. + dendritic cells. Proc. Natl. Acad. Sci. USA 93: 2588.
44. + T cells by monocyte-derived dendritic cells. Blood 96:3490.
45. Dignam, J. D., P. L. Martin, B. S. Shastry, and R. G. Roeder. 1983. Eukaryotic gene transcription with purified components. Methods Enzymol. 101:582.
46. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1999. Current Protocols in Immunology, Vol. 2. John Wiley & Sons, New York, p. 11.4.
47. Lozzio, C. B., and B. B. Lozzio. 1975. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321.
48. Lozzio, B. B., C. B. Lozzio, E. G. Bamberger, and A. S. Feliu. 1981. A multipotential leukemia cell line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 166:546.
49. Tetteroo, P. A., F. Massaro, A. Mulder, R. Schreuder-van Gelder, and A. E. von dem Borne. 1984. Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk. Res. 8:197.
50. Sutherland, J. A., A. R. Turner, P. Mannoni, L. E. McGann, and J. M. Turc. 1986. Ditferentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J. Biol. Response Mod. 5:250.
51. Alitalo, R. 1990. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblast. J. Leuk. Res. 14:501.
52. Whalen, A. M., S. C. Galasinski, P. S. Shapiro, T. S. Nahreini, and N. G. Ahn. 1997. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol. Cell. Biol. 17:1947.
53. Kang, C. D., C. S. Han, K. W. Kim, I. R. Do, C. M. Kim, S. H. Kim, E. Y. Lee, and B. S. Chung. 1998. Activation of NF-κB mediates the PMA-induced differentiation of K562 cells. Cancer Lett. 132:99.
54. Herrera, R., S. Hubbell, S. Decker, and L. Petruzzelli, 1998. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Exp. Cell. Res. 238:407.
55. Swetman, C. A., Y. Leverrier, R. Garg, C. H. Gan, A. J. Ridley, D. R. Katz, and B, M. Chain. 2002. Extension. retraction and contraction in the formation of a dendritic cell dendrite: distinct roles for Rho GTPases. Eur. J. Immunol. 32:2074.
56. Smit, W. M., M. Rijnbeek, C. A. van Bergen, R. A. de Paus, H. A. Vervenne, M. van de Keur, R. Willemze, and J. H. Falkenburg. 1997. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum. Immunol. 53:216.
57. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25.
58. Heaney, M. L., J. C. Vera, M. A. Raines, and D. W. Golde. 1995. Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor a subunits are independently regulated in HL-60 cells. Proc. Natl. Acad. Sci. USA 92:2365.
59. + dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 88:4029.
60. Carrasco, D., R. P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118:1221.
61. Pettit, A. R., C. Quinn, K. P. MacDonald, L. L. Cavanagh, G. Thomas, W. Townsend, M. Handel, and R. Thomas. 1997. Nuclear localization of RelB is associated with effective antigen-presenting cell function. J. Immunol. 159:3681.
62. Clark, G. J., S. Gunningham, A. Troy, S. Vuckovic, and D. N. Hart. 1999. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 98:189.
63. Martin, E., B. O'Sullivan, P. Low, and R. Thomas. 2003. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18:155.
64. Adema, G. J., F. Hartgers, R. Verstraten, E. de Vries, G. Marland, S. Menon, J. Foster, Y. Xu, P. Nooyen, T. McClanahan, et al. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713.
65. Kim, K. W., S. H. Kim, E. Y. Lee, N. D. Kim, H. S. Kang, H. D. Kim, B. S. Chung, and C. D. Kang. 2001. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-κB pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells. J. Biol. Chem. 276:13186.
66. Rescigno, M., M. Martino, C. L. Sutherland, M. R. Gold, and P, Ricciardi-Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188:2175.
67. Ouaaz, F., J. Arron, Y. Zheng, Y. Choi, and A. A. Beg. 2002. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 16:257.
68. Panoskaltsis, N., T. J. Belanger, J. L. Liesveld, and C. N. Abboud. 2002. Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture. Leuk. Res. 26:191.
69. Kobayashi, M., E. Azuma, M. Ido, M. Hirayama, Q, Jiang, S. Iwamoto, T. Kumamoto, H. Yamamoto, M. Sakurai, and Y. Komada. 2001. A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. J. Immunol. 167:3585.
70. Rowley, P. T., B. A. Farley, S. LaBella, R. Giuliano, and J. F. Leary. 1992. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens. Int. J. Cell Cloning 10:232.
71. + bone marrow cells. Blood Cells Mol. Dis. 23:361.
72. + T cells in vitro. Leuk. Res. 24:1049.
73. Alitalo, R. 1987. The bcr-c-abl tyrosine kinase activity is extinguished by TPA in K562 leukemia cells. FEBS Lett. 222:293.
74. Campbell, M. L. D. Lu, J. Q. Guo, and R. B. Arlinghaus. 1993. Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells. Cell Growth Differ. 4:581.
75. Nimmanapalli, R., and K. Bhalla. 2002. Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571. Oncogene 21:8584.
76. Racke, F. K., K. Lewandowska, S. Goueli, and A. N. Goldfarb. 1997. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J. Biol. Chem. 272:23366.
77. Witte, O. 2001. The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology. Semin. Hematol. 38:3.
78. Vigneri, P., and J. Y. Wang. 2001. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat. Med. 7:228.
79. Gishizky, M. L., and O. N. Witte. 1992. BCR/ABL enhances growth of multipotent progenitor cells but does not block their differentiation potential in vitro. Curr. Top. Microbiol. Immunol. 182:65.